Assembly Biosciences, Inc. (ASMB) vs Puma Biotechnology, Inc. (PBYI)
Assembly Biosciences, Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Puma Biotechnology, Inc. are of similar size ($506.9M and $481.7M). Puma Biotechnology, Inc. trades at the lower P/E: 18.1× against 23.2×. Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs −0.06%) and the higher return on invested capital (42.6% vs 0.00%). Across the 18 metrics below, Puma Biotechnology, Inc. leads on 11 and Assembly Biosciences, Inc. on 7.
Valuation
Profitability
| Metric | ASMB | PBYI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 74.83% | 65.16% |
| Operating margin | (11.75%) | 13.16% | 0.00% |
| Net margin | (0.06%) | 11.55% | 0.00% |
| Free cash flow margin | (51.53%) | 17.79% | 0.00% |
| Return on equity | (0.03%) | 21.97% | (57.72%) |
| Return on assets | (0.02%) | 13.78% | (49.22%) |
| Return on invested capital | 0.00% | 42.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack